This NIH funding opportunity supports the development of non-addictive analgesic therapeutics, including small molecules and biologics, to treat pain. It is part of the HEAL Initiative and may optionally include clinical trials (UG3/UH3). Specific eligibility and application details are not provided.
Eligibility details not specified in the grant listing. Contact the funding organization for requirements.
